Insider · CIK 0001816838

Owen Adams Catherine

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816838

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,816 sh	—	—	10,865
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,816 sh	—	—	0
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,927 sh	—	—	2,927
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	14,950
2026-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,976 sh	—	—	8,049
2026-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,976 sh	—	—	0
2026-03-25	ACADACADIA PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−11.6K sh	$21.47	−$250K	14,803
2026-03-24	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+23.5K sh	—	—	26,444
2026-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−23.5K sh	—	—	70,530
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+263K sh	—	—	263,005
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+76.5K sh	—	—	76,509
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,120 sh	—	—	6,073
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,120 sh	—	—	0
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,816 sh	—	—	2,816
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,768
2025-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,977 sh	—	—	3,953
2025-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,977 sh	—	—	1,976
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+320K sh	—	—	319,976
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+94K sh	—	—	94,039
2024-09-23	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+353K sh	—	—	353,261
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,120 sh	—	—	2,120
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,774
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,976 sh	—	—	1,976
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,976 sh	—	—	3,953
2024-06-06	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+5,929 sh	—	—	5,929
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+33.2K sh	—	—	33,177
2023-06-08	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+53.5K sh	—	—	53,500
2022-06-08	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2021-06-09	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,439
2020-07-29	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28.9K sh	—	—	28,879
2020-07-29	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28.9K sh	—	—	28,879

Recent filings

Accepted (ET)
Jun 234
Owen Adams Catherine0001439222-26-000097
SEC(opens sec.gov)
Jun 164
Owen Adams Catherine0001439222-26-000077
SEC(opens sec.gov)
Mar 264
Owen Adams Catherine0001816838-26-000003
SEC(opens sec.gov)
Mar 104
Owen Adams Catherine0001816838-26-000002
SEC(opens sec.gov)
Jun 234
Owen Adams Catherine0001439222-25-000051
SEC(opens sec.gov)
Jun 174
Owen Adams Catherine0001439222-25-000043
SEC(opens sec.gov)
Mar 264
Owen Adams Catherine0001415889-25-009067
SEC(opens sec.gov)
Sep 254
Adams Catherine Owen0001415889-24-023975
SEC(opens sec.gov)

Companies

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139